Luteolin Nanoparticle in Chemoprevention: In Vitro and In Vivo Anticancer Activity

作者: Debatosh Majumdar , Kyung-Ho Jung , Hongzheng Zhang , Sreenivas Nannapaneni , Xu Wang

DOI: 10.1158/1940-6207.CAPR-13-0230

关键词:

摘要: Cancer prevention (chemoprevention) by using naturally occurring dietary agents has gained immense interest because of the broad safety window these compounds. However, many compounds are hydrophobic and poorly soluble in water. They frequently display low bioavailability, poor systemic delivery, efficacy. To circumvent this problem, we explored a novel approach toward chemoprevention nanotechnology to deliver luteolin, natural compound present green vegetables. We formulated water-soluble polymer-encapsulated Nano-Luteolin from studied its anticancer activity against lung cancer head neck cancer. In vitro studies demonstrated that, like inhibited growth cells (H292 cell line) squamous carcinoma (SCCHN) (Tu212 line). Tu212 cells, IC50 value was 4.13 μmol/L, that luteolin 6.96 μmol/L. H292 15.56 14.96 vivo tumor xenograft mouse model significant inhibitory effect on SCCHN comparison luteolin. Our results suggest nanoparticle delivery advantages may have potential application clinical settings.

参考文章(63)
Ruxandra Gref, Yoshiharu Minamitake, Maria Teresa Peracchia, Avi Domb, Vladimir Trubetskoy, Vladimir Torchilin, Robert Langer, Poly(ethyleneglycol)-Coated Nanospheres: Potential Carriers for Intravenous Drug Administration Pharmaceutical Biotechnology. ,vol. 10, pp. 167- 198 ,(2002) , 10.1007/0-306-46803-4_6
Pan Mh, Cheng Al, Jee Sh, Lin Br, Ho Yf, Chen Ca, Pu Ys, Chen Gs, Ko Jy, Hsu Mm, Ming-Shiang W, Shen Ts, Wang Yj, Chen Tm, Tsai Cc, Hsu Ch, Lin Jk, Yu Hs, Lin Jt, Lai Mk, Hsieh Cy, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research. ,vol. 21, pp. 2895- 2900 ,(2001)
David A. LaVan, David M. Lynn, Robert Langer, Moving smaller in drug discovery and delivery Nature Reviews Drug Discovery. ,vol. 1, pp. 77- 84 ,(2002) , 10.1038/NRD707
Katherine MW Pisters, Robert A Newman, Brenda Coldman, Dong M Shin, Fadlo R Khuri, Waun Ki Hong, Bonnie S Glisson, Jin S Lee, None, Phase I Trial of Oral Green Tea Extract in Adult Patients With Solid Tumors Journal of Clinical Oncology. ,vol. 19, pp. 1830- 1838 ,(2001) , 10.1200/JCO.2001.19.6.1830
Xueting Cai, Tingmei Ye, Chao Liu, Wuguang Lu, Min Lu, Juan Zhang, Min Wang, Peng Cao, Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells. Toxicology in Vitro. ,vol. 25, pp. 1385- 1391 ,(2011) , 10.1016/J.TIV.2011.05.009
Zhuo Li Yang, Xin Ru Li, Ke Wei Yang, Yan Liu, Amphotericin B-loaded poly(ethylene glycol)-poly(lactide) micelles: preparation, freeze-drying, and in vitro release. Journal of Biomedical Materials Research Part A. ,vol. 85, pp. 539- 546 ,(2008) , 10.1002/JBM.A.31504
J. Fang, Q. Zhou, X.-l. Shi, B.-h. Jiang, Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells Carcinogenesis. ,vol. 28, pp. 713- 723 ,(2006) , 10.1093/CARCIN/BGL189
Nobuhiro Nishiyama, Nanomedicine: nanocarriers shape up for long life. Nature Nanotechnology. ,vol. 2, pp. 203- 204 ,(2007) , 10.1038/NNANO.2007.88
W. K. Hong, Recent Advances in Chemoprevention of Cancer Science. ,vol. 278, pp. 1073- 1077 ,(1997) , 10.1126/SCIENCE.278.5340.1073